Former CEO Anne Wojcicki’s nonprofit, the TTAM Research Institute, won a second auction to acquire 23andMe’s assets for $305 million, surpassing Regeneron’s prior bid. Agreement includes protections for consumer privacy and genetic data, along with commitments for identity theft monitoring and governance. This development rescues the genetic testing firm from bankruptcy and aligns with Wojcicki’s vision to advance genomic medicine access.